RICHLAND, Wash.----IsoRay Inc. , a medical isotope company focusing on the treatment of prostate and other malignant diseases through use of its proprietary radioisotope technology, announced today that director Dwight Babcock has been appointed Chairman of the Company's Board of Directors, and will also be Interim Chief Executive Officer, following the resignation for personal reasons of Roger ...
More...
More...